Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
New movies to watch this weekend: See 'Wake Up Dead Man: A Knives Out Mystery' in theaters, rent 'Bugonia,' stream 'Caught Stealing' on Netflix - 2Rio Tinto resumes operations at three Pilbara port terminals after cyclone Narelle
- 3U.S. overhauls childhood vaccine schedule, recommends fewer shots
- 4Dwayne ‘the Rock’ Johnson opens up about being the 'new guy' again — and why this moment feels like a new life
- 5These men carry towers of birds through Mexico's streets. They say their tradition is dying out.
- Feeling wonder every day improves our health. Here’s how to do it.
- Daily Briefing: A bad flu season gets worse
- Easter Island quarry reveals how Polynesians made enigmatic stone statues
- Europe picks companies to help build Argonaut moon lander
- Humanity is back at the moon! Artemis 2 astronauts arrive in lunar space
- Cheetah, Hammerhead Shark, and 38 Other Animals in Danger of Extinction Receive New International Protections from U.N.
- Stunning new James Webb Space Telescope images reveal 'hidden' stars being born
- Monetary Freedom Guide: Plan Your Future
- Surging measles cases are 'fire alarm' warning that other diseases could be next
